Stan Gee Louie, PharmD

Professor of Clinical Pharmacy & Director of Clinical Experimental Therapeutics Program · USC School of Pharmacy

Stan Gee Louie is a clinical and translational pharmacologist with three decades of clinical and drug development experience.

Accelerating wound healing properties Developing novel drug therapy to inhibit chronic inflammation in cancer, diabetes, and neurodegenerative disease. Drug development targeting viral infection and cancer. Metabolomic approaches to dissecting the molecular mechanism(s) driving pharmacologic responses.

Jan D. Hirsch

Founding Dean, School of Pharmacy and Pharmaceutical Sciences · UC Irvine

Jan Hirsch's research interests are focused in the areas of pharmacoeconomics and outcomes research.

Comprehensive Medication Management (CMM) Medication Therapy Management Clinical Pharmacy Pharmacoeconomics Drug Development

Thomas D. Roper, Ph.D.

Director, Pharmaceutical Engineering and Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering

Dr. Roper specializes in efforts to bring engineering and science closer to patients who utilize medicines via novel technologies.

Metabolic Engineering and Biocatalysis 3D Printing of Dose Forms Long Acting Therapy Development Nanomaterials and Particle Sciences Continuous Chemical Reaction Engineering

Vassilios Papadopoulos, DPharm, PhD, DSc (Hon)

Dean, USC School of Pharmacy, John Stauffer Dean's Chair in Pharmaceutical Sciences & Professor of Pharmacology and Pharmaceutical Sciences · USC School of Pharmacy

An expert in pathophysiology and treatment of diseases related to altered steroid hormone synthesis.

Steroid hormone biosynthesis Hypogonadism Cancer Endocrine Pathologies Male Reproductive Disorders

Julio A. Camarero, PhD

John A. Biles Professor in Pharmaceutical Sciences · USC School of Pharmacy

An expert in biological therapeutics, microbial pathogenicity, and protein and peptide therapeutics.

Inteins Bio-organic Chemistry Biological Therapeutics Microbial Pathogenicity Protein and peptide therapeutics

B. Frank Gupton, Ph.D.

Floyd D. Gottwald, Jr. Chair in Pharmaceutical Engineering; Chair, Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering

Professor Gupton's research is focused on the development of new technologies that will streamline organic synthesis

Cross-Coupling Catalysis Flow Chemistry / Continual Chemical Processing Organic Synthesis in Pharmaceutical Applications

Prof. Elias Mossialos

Professor of Health Policy · Department of Social Policy, London School of Economics

Professor Mossialos's research interests are health systems and policy, with a specific focus on the impact of EU law on health care systems

Long Term Care European Health Policy Comparative Health Policy Funding Health Care Health Services Research

Jing Liang, MD, PhD

Professor · USC School of Pharmacy

Expert in drug development. Established targeting gephyrin-GABAAR pathway, a NOVEL THEORY, to intervene Alzheimer disease

Neurodegenerative Disease Sleep Disorders Neuroscience Drug Development GABA A Receptor

Bin Chen

Assistant Professor of Pediatrics and Human Development · Michigan State University

Dr. Chen is the founding member of DahShu, a non-profit organization to promote research and education in data sciences.

Cancer Therapy Drug Repositioning Translational Bioinformatics AI Big Data

Dr Afzal-Ur-Rahman Mohammed

Professor, Pharmacy · Aston University

Afzal-Ur-Rahman Mohammed's research interests include formulation development and optimization of orally disintegrating tablets.

Dry Particle Coating Technology Tablets Pharmacy Pharmaceuticals Stability Testing

Klaus Romero, MD, MS, FCP

Adjunct Professor of Clinical Pharmacy · USC School of Pharmacy

Klaus Romero is a clinical pharmacologist and epidemiologist who has developed models to predict the efficacy and safety of medications.

Quantitative Medicine Pharmacoepidemiology Pharmacometrics

Wujie Zhang, Ph.D.

Associate Professor · Milwaukee School of Engineering

Dr. Wujie Zhang is an expert in biomaterials, tissue engineering, stem cell-based medicine, micro/nanotechnology, and drug delivery.

Biomaterials Regenerative Medicine and Tissue Engineering Micro/Nano-technology Drug Delivery Stem Cell Research

Karl Peace

Professor, Georgia Cancer Coalition Distinguished Cancer Scholar, Jiann-Ping College of Public Health · Georgia Southern University

Karl Peace researches biostatistics, clinical trials and drug research and development.

Clinical Trials Pharmaceutical Research Health & Disease Health Sciences Biostatistics

Melina Kibbe

Colin G. Thomas, Jr., MD Distinguished Professor · UNC-Chapel Hill

Dr. Kibbe’s expertise is in open and endovascular surgery and in novel therapies to treat cardiovascular disease

Mentorship and Career Development Gender Inclusion Sex Bias Biomedical Engineering Nanotechnology

Yong (Tiger) Zhang, PhD

Assistant Professor of Pharmacology and Pharmaceutical Sciences · USC School of Pharmacy

Yong (Tiger) Zhang is an expert in chemical biology, drug design and discovery, protein engineering, and immunotherapy.

Nanomedicine Protein Biosynthesis Immunotherapy Drug Design and Discovery Chemical Biology

Annie Wong-Beringer, PharmD, FCCP, FIDSA

Associate Dean for Research Affairs & Professor of Clinical Pharmacy · USC School of Pharmacy

An expert in bacterial resistance and virulence, host microbial interactions and host immune response.

Coronavirus Host microbial interactions Host immune response Pseudomonas aeruginosa Antimicrobial Resistance

Adam Buckley

Vice President, Operations · VBI Vaccines

Adam Buckley is an expert in the biotechnology industry, specializing in the areas vaccines, technology transfer and drug development.

Lifesciences Drug Development Vaccines Biotechnology Technology Transfer

Riccardo Panicucci

Senior VP CMC · QED Therapeutics and Origin Biosciences

Riccardo Panicucci is an expert in the pharmaceutical industry, biotechnology, clinical development, and biopharmaceuticals.

Technology Transfer Biotechnology Clinical Development Drug Discovery Drug Development

Karla MacDonald

Vice President, Communication and Patient Advocacy · Ipsen

Karla MacDonald is an expert in strategy, leading communications and building talent for companies ranging from biotechs to large pharma.

Corporate Communications Pharmaceutical Industry Strategic Communications Patient Advocacy Drug Development

Paul Jansen

Consultant, Board Member and Advisor · Haselmeier Group

Paul Jansen is an experienced pharmaceutical industry professional with expertise in drug and biologics device development.

Biotechnology Pharmaceutical Industry Drug Development Biologics Device Development Product Launch